BioCentury | Aug 20, 2015
Distillery Therapeutics

Therapeutics: Transglutaminase 2 (TGM2; TG2)

Cancer INDICATION: Cancer; ophthalmic In vitro and mouse studies suggest enhancing TGM2 levels could help treat cancer and ophthalmic diseases by inhibiting angiogenesis. In a human umbilical vein endothelial cell line, an shRNA targeting TGM2...
BioCentury | Aug 17, 2015
Company News

Quantum Genomics, University of Ottawa, Institut National de la Sante et de la Recherche Medicale deal

...royalties. INSERM and the university did not respond to inquiries. CIRB is located at the College de France...
BioCentury | Jan 1, 2007
Company News

Transgene scientific advisory board update

...functional genomics at the University of Sheffield; Philippe Kourilsky, professor of molecular immunology at the College de France...
BioCentury | Oct 7, 2002
Company News

Cytochroma scientific advisory board update

...Cytochroma Inc. , Markham, Ontario Business: Metabolic Appointed: Pierre Chambon, professor at the College de France; John Falck...
BioCentury | Jun 11, 2001
Company News

Ethypharm scientific advisory board update

...Ethypharm S.A. , Paris, France Business: Drug delivery Appointed: Jean-Marie Lehn, professor at the College de France; James...
BioCentury | Jan 16, 2001
Company News

ExonHit Therapeutics SA scientific advisory board update

...SA, Paris, France Business: Enabling technology Appointed: Pierre Corvol, professor of experimental medicine at the College de France...
BioCentury | Apr 5, 1999
Politics, Policy & Law

Les penseurs

...Genevieve Vinay and Philippe Kourilsky, an academic scientist who is a professor at the prestigious College de France...
BioCentury | Oct 14, 1996
Company News

Massachusetts General Hospital, College de France other research news

...orally administered as therapy for inflammatory bowel disease, researchers suggested. Massachusetts General Hospital, Boston, Mass. College de France...
Items per page:
1 - 8 of 8
BioCentury | Aug 20, 2015
Distillery Therapeutics

Therapeutics: Transglutaminase 2 (TGM2; TG2)

Cancer INDICATION: Cancer; ophthalmic In vitro and mouse studies suggest enhancing TGM2 levels could help treat cancer and ophthalmic diseases by inhibiting angiogenesis. In a human umbilical vein endothelial cell line, an shRNA targeting TGM2...
BioCentury | Aug 17, 2015
Company News

Quantum Genomics, University of Ottawa, Institut National de la Sante et de la Recherche Medicale deal

...royalties. INSERM and the university did not respond to inquiries. CIRB is located at the College de France...
BioCentury | Jan 1, 2007
Company News

Transgene scientific advisory board update

...functional genomics at the University of Sheffield; Philippe Kourilsky, professor of molecular immunology at the College de France...
BioCentury | Oct 7, 2002
Company News

Cytochroma scientific advisory board update

...Cytochroma Inc. , Markham, Ontario Business: Metabolic Appointed: Pierre Chambon, professor at the College de France; John Falck...
BioCentury | Jun 11, 2001
Company News

Ethypharm scientific advisory board update

...Ethypharm S.A. , Paris, France Business: Drug delivery Appointed: Jean-Marie Lehn, professor at the College de France; James...
BioCentury | Jan 16, 2001
Company News

ExonHit Therapeutics SA scientific advisory board update

...SA, Paris, France Business: Enabling technology Appointed: Pierre Corvol, professor of experimental medicine at the College de France...
BioCentury | Apr 5, 1999
Politics, Policy & Law

Les penseurs

...Genevieve Vinay and Philippe Kourilsky, an academic scientist who is a professor at the prestigious College de France...
BioCentury | Oct 14, 1996
Company News

Massachusetts General Hospital, College de France other research news

...orally administered as therapy for inflammatory bowel disease, researchers suggested. Massachusetts General Hospital, Boston, Mass. College de France...
Items per page:
1 - 8 of 8